Lamond David (CIK 0001770790)

Latest company ownership

Shares held
27,000
Last filed at
Jun 7, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 12, 2023 Dec 14, 2023 Quince Therapeutics, Inc. Director Buy 72.5 +67,881 0.62% ✗ $69.2K
Dec 5, 2023 Dec 7, 2023 Quince Therapeutics, Inc. Director Buy 82.5 +57,369 1.35% ✗ $58.1K
Nov 29, 2023 Dec 1, 2023 Quince Therapeutics, Inc. Director Buy 78.8 +43,134 1.02% ✗ $40.5K
Aug 30, 2023 Aug 31, 2023 Quince Therapeutics, Inc. Director Buy 82.5 +82,052 1.98% ✗ $107.9K
Aug 15, 2023 Aug 17, 2023 Quince Therapeutics, Inc. Director Buy 92.5 +250,000 6.44% ✗ $325.7K
Mar 24, 2021 Mar 24, 2021 Quince Therapeutics, Inc. Director Buy 87.5 +50,000 1.38% ✗ $1.7M
Mar 4, 2021 Mar 5, 2021 Quince Therapeutics, Inc. Director Buy 87.5 +50,000 2.44% ✗ $1.8M
Jun 4, 2020 Jun 8, 2020 Quince Therapeutics, Inc. Director Buy 87.5 +49,125 2.46% ✗ $2.1M
May 15, 2020 May 19, 2020 Quince Therapeutics, Inc. Director Buy 87.5 +44,648 2.28% ✗ $2.5M